coronary disease/valvular disease. -
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Including criteria: ASA 2,3; normal troponin one level; no recent myocardial infarction; ejection fraction more than 35%; no renal and hepatic dysfunction; no arterio-venous fistula; no lymph edema. Excluding criteria: ASA 4 or more; elevated baseline troponin I; myocardial infarction in recent 4 weeks; ejection fraction less than 35%; renal dysfunction; arterio-venous fistula; lymph edema; severe endocrine or hepatic dysfunction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Troponin I. Timepoint: time0, 6 and 24 hour after intervention. Method of measurement: quantitative troponin kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intubation time. Timepoint: 6 hour, 24 hour. Method of measurement: clock.;Systolic and diastolic pressure. Timepoint: time 0,time 6,time 24. Method of measurement: Sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahwaz University of Medical Science